 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | SIRT1 ↓ ↑ | SIRT2 ↓ ↑ | SIRT3 ↓ ↑ | SIRT5 ↓ ↑ | SIRT6 ↓ ↑ | SIRT7 ↓ ↑ | Sirtuin ↓ ↑ | 其他靶点 | 纯度 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selisistat | ++++ SIRT1, IC50: 38 nM | 99%+ | |||||||||||||||||
| Resveratrol | ✔ | 98% | |||||||||||||||||
| Inauhzin | ✔ | p53 | 99%+ | ||||||||||||||||
| Suramin sodium salt | +++ SirT1, IC50: 297 nM | ++ SirT5, IC50: 22 μM | 99%+ | ||||||||||||||||
| Salermide | ✔ | 99% | |||||||||||||||||
| Quercetin Dihydrate | ✔ | 95% | |||||||||||||||||
| Sirtinol | + SIRT1, IC50: 131 μM | ++ SIRT2, IC50: 38 μM | 98%+ | ||||||||||||||||
| AGK2 | +++ SIRT2, IC50: 3.5 μM | 99%+ | |||||||||||||||||
| Tenovin-3 | ✔ | p53 | 99%+ | ||||||||||||||||
| 3-TYP | ++++ SIRT1, IC50: 88 nM | ++++ SIRT2, IC50: 92 nM | ++++ SIRT3, IC50: 16 nM | 95% | |||||||||||||||
| Tenovin-6 | ++ SIRT1, IC50: 21 μM | ++ SIRT2, IC50: 10 μM | + SIRT3, IC50: 67 μM | p53 | 99%+ | ||||||||||||||
| SirReal2 | +++ SIRT2, IC50: 140 nM | 99%+ | |||||||||||||||||
| Thiomyristoyl | ++++ SIRT2, IC50: 28 nM | 99%+ | |||||||||||||||||
| Et-29 | ✔ | 98% | |||||||||||||||||
| OSS_128167 | + SIRT1, IC50: 1578 μM | + SIRT2, IC50: 751 μM | + SIRT6, IC50: 89 μM | 98% | |||||||||||||||
| SIRT7 inhibitor 97491 | +++ SIRT7, IC50: 325 nM | 97% | |||||||||||||||||
| Nicotinamide | ✔ | 99+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | Sirtuin (Sirt) 1 and 2 are members of the NAD+-dependent class III histone deacetylase family that are involved in various cellular events, such as transcriptional silencing, chromatin remodeling, and lifespan duration. Salermide is a potent inhibitor of both Sirt1 and Sirt2. It dose-dependently inhibited human Sirt1 protein with 80% inhibition at 90μM. Salermide shows more efficient inhibitory effect on Sirt2 with 80% inhibition at 25μM. Treatment with 100μM Salermide for 24h induced the decrease of cell numbers in cancer cell lines derived from leukaemia (MOLT4, KG1A, K562), lymphoma (Raji), colon (SW480) and breast (MDA-MB-231) primary malignancies, but not in non-tumorigenic MRC5 cells. The IC50 values of Salermide in MOLT4, MDA-MB-231 and SW480 cancer cells were around 20, 110, and 100 μM, respectively. After 72-h incubation with 100 μM Salermide, only 10% of KG1A cells and 50% of Raji and K562 cells were viable. An increase of cytosolic-activated caspase 3 and a decrease of mitochondrial-cytochrome c were observed in Salermide-treated cells 2h post treatment. Twenty-four-hour incubation of 25 and 100μM Salermide induced slight tubulin acetylation in MOLT4, MDA-MB-231 and SW480 cells. Intraperitoneal injection of 100μM Salermide over 34 days in nude mice showed no apparent toxicity as monitored by diet consumption, body-weight gain, and postural and behavioral changes[2]. | 
| Concentration | Treated Time | Description | References | |
| Acanthamoeba castellanii trophozoites | 100 µM | 24 and 48 hours | Inhibited the proliferation of Acanthamoeba castellanii trophozoites | Parasit Vectors. 2020 Jul 22;13(1):368. | 
| H1650 | 20 µM | 24 hours | To evaluate the apoptosis effect of Salermide on H1650 cells, results showed H1650 cells were particularly sensitive to Salermide. | J Cell Mol Med. 2012 Jul;16(7):1618-28. | 
| HCT116 Oxa-R cells | 20 µM | 24 hours | To evaluate the effect of CAY10602 on oxaliplatin resistance, results showed that CAY10602 enhancement of SIRT1 expression decreased the resistance of HCT116 Oxa-R cells to oxaliplatin. | World J Gastroenterol. 2025 Mar 21;31(11):100785. | 
| HCT116 Oxa-R cells | 10 µM | 24 hours | To evaluate the effect of Salermide on oxaliplatin resistance, results showed that Salermide inhibition of SIRT1 expression increased the resistance of HCT116 Oxa-R cells to oxaliplatin. | World J Gastroenterol. 2025 Mar 21;31(11):100785. | 
| BxPC-3 cells | 5-100 µM | 24 hours | To evaluate the effect of Salermide alone or in combination with EF24 on the viability of BxPC-3 cells. Results showed that Salermide alone significantly reduced the viability of BxPC-3 cells with an IC50 value of approximately 40 µM. | EXCLI J. 2016 Apr 4;15:246-55. | 
| H157 | 50 µM | 24, 48 hours | To evaluate the time-dependent apoptosis induced by Salermide, results showed apoptosis started at 24 hrs and peaked at 48 hrs. | J Cell Mol Med. 2012 Jul;16(7):1618-28. | 
| Acanthamoeba castellanii trophozoites | 100 µM | 24, 48, 72 hours | Inhibited the proliferation of Acanthamoeba castellanii trophozoites | Parasit Vectors. 2020 Jul 22;13(1):368. | 
| Human brain microvascular endothelial cells and astrocytes co-culture model | 50 µM | 30 min pretreatment | Sirt1 inhibition significantly reduced BBB permeability (increased TEER) and attenuated OGD-induced apoptosis and mitochondrial ROS generation | Redox Biol. 2018 Apr;14:229-236. | 
| SKOV-3 cells | 50 µM | 48 hours | Comparison of anticancer effects between MHY2256 and salermide in SKOV-3 cells, showing IC50 values of salermide as 36.5-50.9 μM | Int J Biol Sci. 2016 Dec 6;12(12):1555-1567. | 
| MCF-7 cells | 50 µM | 48 hours | Comparison of anticancer effects between MHY2256 and salermide in MCF-7 cells, showing IC50 values of salermide as 36.5-50.9 μM | Int J Biol Sci. 2016 Dec 6;12(12):1555-1567. | 
| H1792 | 12.5, 25, 50 µM | 48 hours | To evaluate the effect of Salermide on cell growth, results showed Salermide induced growth inhibition in a concentration-dependent manner. | J Cell Mol Med. 2012 Jul;16(7):1618-28. | 
| Ishikawa endometrial cancer cells | 0.1–50 µM | 48 hours | To compare the cytotoxicity of MHY2256 and Salermide on Ishikawa cells. Results showed that the IC50 value of MHY2256 was approximately 10-fold lower than that of salermide. | Int J Mol Sci. 2018 Sep 13;19(9):2743. | 
| LLCMK2 cells | 2 µM | 48 hours | Salermide reduced the number of intracellular parasites in vitro infection assays with minimal effects on host cell viability. | Antimicrob Agents Chemother. 2015 Aug;59(8):4669-79. | 
| MiaPaca-2 pancreatic cancer cells | 25–50 µM | 72 hours | Inhibited SIRT2 activity, reduced c-Myc protein expression, and suppressed cell proliferation | Cell Death Differ. 2013 Mar;20(3):503-14. | 
| BE(2)-C neuroblastoma cells | 25–50 µM | 72 hours | Inhibited SIRT2 activity, reduced N-Myc protein expression, and suppressed cell proliferation | Cell Death Differ. 2013 Mar;20(3):503-14. | 
| Trypanosoma cruzi epimastigotes | 5 µM | 72 hours | Salermide significantly inhibited parasite growth and differentiation, with an EC50 of 10.6 μM. | Antimicrob Agents Chemother. 2015 Aug;59(8):4669-79. | 
| Acanthamoeba castellanii encysting cells | 100 µM | 72 hours | Inhibited the encystation of Acanthamoeba castellanii | Parasit Vectors. 2020 Jul 22;13(1):368. | 
| Administration | Dosage | Frequency | Description | References | ||
| Zebrafish | Dmd mutant zebrafish | Embryo bath | 1 μM | From 1 dpf to 4 dpf, changing the treatment solution daily | To evaluate the effect of Salermide in combination with oxamflatin on the skeletal muscle structure of dmd mutant zebrafish. Results showed that the combination significantly ameliorated skeletal muscle degeneration. | Skelet Muscle. 2020 Oct 15;10(1):29 | 
| BALB/c nude mice | Subcutaneous xenograft model of HCT116 Oxa-R cells in nude mice | Subcutaneous injection | 10 mg/kg | Three times a week until tumor volume reached 1500 mm³ | To evaluate the effect of CAY10602 on oxaliplatin resistance, results showed that CAY10602 enhanced the growth-inhibitory effect of oxaliplatin on HCT116 Oxa-R cells. | World J Gastroenterol. 2025 Mar 21;31(11):100785. | 
| BALB/c mice | Chagas disease model | Intraperitoneal injection | 100 μM | Daily for 12 days | Salermide partially controlled in vivo infection, reducing parasitemia. | Antimicrob Agents Chemother. 2015 Aug;59(8):4669-79. | 
| Nude mice | MCF-7 xenograft model | Intraperitoneal injection | 30 mg/kg | Once per week for 4 weeks | Evaluation of the antitumor effects of salermide in the MCF-7 xenograft model, showing significant inhibition of tumor growth | Int J Biol Sci. 2016 Dec 6;12(12):1555-1567. | 
| Nude mice | Ishikawa endometrial cancer cell xenograft model | Intraperitoneal injection | 30 mg/kg | Once per week for 30 days | To evaluate the antitumor effect of Salermide on Ishikawa cell xenograft model. Results showed that salermide significantly inhibited tumor growth. | Int J Mol Sci. 2018 Sep 13;19(9):2743. | 
| Mice | Photothrombotic stroke model | Intracerebroventricular injection | 400 μM | Single administration, 1 hour after stroke | To study the effect of Salermide on infarction volume and apoptotic index after stroke. Results showed that Salermide did not significantly alter infarction volume or apoptotic index compared to control samples. | Front Physiol. 2022 Apr 27;13:782684 | 
| Dose | Mice: 30 mg/kg[2] (i.p.) | 
| Administration | i.p. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 2.54mL 0.51mL 0.25mL | 12.68mL 2.54mL 1.27mL | 25.35mL 5.07mL 2.54mL | |
| CAS号 | 1105698-15-4 | 
| 分子式 | C26H22N2O2 | 
| 分子量 | 394.47 | 
| SMILES Code | CC(C1=CC=CC=C1)C(NC2=CC=CC(/N=C/C3=C4C=CC=CC4=CC=C3O)=C2)=O | 
| MDL No. | MFCD12912446 | 
| 别名 | |
| 运输 | 蓝冰 | 
| InChI Key | HQSSEGBEYORUBY-UHFFFAOYSA-N | 
| Pubchem ID | 135659046 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C | 
| 溶解方案 | DMSO: 50 mg/mL(126.75 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1